
Clinical-stage company developing transformative medicines that dramatically improve the lives of patients with life-altering immune diseases.
Completed reverse merger in 2023
Clinical-stage company developing transformative medicines that dramatically improve the lives of patients with life-altering immune diseases.
Completed reverse merger in 2023